Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Explore what bad habits lead to overspending and how to curb them. Implement practical tips to protect your wallet and save more today.
7,290 articlesNovo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
A surge in AI workloads is testing chipmakers worldwide. This piece explains why tsmc can't make chips fast enough, w...
AI spending is roaring as hyperscale cloud providers expand data-center capacity. This article highlights two stock i...
A leading analyst warns of multi-year shortages coming optical as AI data-center growth strains suppliers. LUMENTUM a...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Keller Williams rolls out a redesigned Command CRM with more than 75 integrations, backed by Stone Point Capital. The...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Houston-based Epique Realty doubles down on specialized AI to streamline agent workflows, launching EpiqueX to automa...
In 2026, real estate agents increasingly rely on mobile tools to manage leads, market listings, and discuss loan opti...
HomeServices of America unveils Maestro, an AI-backed operating system for its real estate agents, consolidating sear...
MoneyHero fans will be watching the 2025 earnings with a keen eye for growth, margins, and the companys path to profi...
When rhythm pharma (rytm) releases earnings, investors get a window into revenue growth, cash health, and pipeline pr...